1. Home
  2. BIAF vs OP Comparison

BIAF vs OP Comparison

Compare BIAF & OP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIAF
  • OP
  • Stock Information
  • Founded
  • BIAF 2014
  • OP 2021
  • Country
  • BIAF United States
  • OP Greece
  • Employees
  • BIAF N/A
  • OP N/A
  • Industry
  • BIAF Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • OP
  • Sector
  • BIAF Health Care
  • OP
  • Exchange
  • BIAF Nasdaq
  • OP Nasdaq
  • Market Cap
  • BIAF 12.2M
  • OP 14.3M
  • IPO Year
  • BIAF 2022
  • OP N/A
  • Fundamental
  • Price
  • BIAF $0.35
  • OP $0.30
  • Analyst Decision
  • BIAF Hold
  • OP
  • Analyst Count
  • BIAF 1
  • OP 0
  • Target Price
  • BIAF N/A
  • OP N/A
  • AVG Volume (30 Days)
  • BIAF 12.3M
  • OP 10.3M
  • Earning Date
  • BIAF 08-13-2025
  • OP 08-06-2025
  • Dividend Yield
  • BIAF N/A
  • OP N/A
  • EPS Growth
  • BIAF N/A
  • OP N/A
  • EPS
  • BIAF N/A
  • OP N/A
  • Revenue
  • BIAF $8,809,228.00
  • OP $25,702,000.00
  • Revenue This Year
  • BIAF N/A
  • OP N/A
  • Revenue Next Year
  • BIAF $20.00
  • OP N/A
  • P/E Ratio
  • BIAF N/A
  • OP N/A
  • Revenue Growth
  • BIAF 78.40
  • OP 35.58
  • 52 Week Low
  • BIAF $0.16
  • OP $0.30
  • 52 Week High
  • BIAF $2.99
  • OP $3.17
  • Technical
  • Relative Strength Index (RSI)
  • BIAF 56.35
  • OP 34.84
  • Support Level
  • BIAF $0.27
  • OP $1.49
  • Resistance Level
  • BIAF $0.38
  • OP $2.50
  • Average True Range (ATR)
  • BIAF 0.04
  • OP 0.28
  • MACD
  • BIAF 0.01
  • OP -0.17
  • Stochastic Oscillator
  • BIAF 73.43
  • OP 0.45

About BIAF bioAffinity Technologies Inc.

bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.

About OP OceanPal Inc.

OceanPal Inc is a provider of shipping transportation services. It specializes in the ownership of vessels. Each of its vessels is owned through a separate wholly-owned subsidiary. The company includes Dry Bulk segment and Tanker segment. Majority of revenue is Dry Bulk segment.

Share on Social Networks: